多功能纳米免疫刺激剂:克服免疫抑制的微环境,用于抗瘤免疫治疗
Guanhong Guo1, Wenda Zhong1, Huishuang Zhao1
1School of Pharmacy, Shandong Second Medical University, Weifang, 261053, P. R. China.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)
|December 12, 2025
概括
这项研究引入了一种多功能免疫刺激剂,通过减少谷氨和缺氧来对抗免疫抑制瘤微环境. 这种方法增强了抗瘤免疫疗法的有效性,并促进了免疫细胞的透.
科学领域:
- 生物医学工程 生物医学工程
- 免疫学 免疫学 免疫学
- 癌症研究 癌症研究
背景情况:
- 抗瘤免疫疗法至关重要,但受到免疫抑制性瘤微环境 (TME) 的限制.
- 在TME中,主要的免疫抑制因素包括缺氧,高谷氨 (GSH) 水平和免疫逃避.
- 瘤异质性和TME复杂性需要超越单一治疗的多方面的治疗策略.
研究的目的:
- 开发一种多功能免疫刺激剂 (3IZH),能够同时增强免疫力,降低GSH的调节,并缓解TME内的缺氧.
- 为了研究3IZH与低氧诱导因子1-alpha (HIF-1α) 抑制剂 (digoxin) 对增强抗瘤反应的协同效应.
主要方法:
- 设计和合成一个多功能免疫刺激器 (3IZH),释放光敏剂 (3ICy5) 和铁离子在TME.
- 通过氧化还原反应研究Fe离子介导的GSH消耗和缺氧缓解.
- 评估3ICy5诱导的内等质网膜 (ER) 应激,DAMP释放,免疫细胞死亡 (ICD) 和铁亡.
- 在双边瘤携带的小鼠模型中评估与狄戈辛的联合治疗.
主要成果:
- 3IZH有效地消耗了GSH,并在TME中减轻了缺氧.
- 3ICy5诱导ER压力,DAMPs释放,ICD,并通过减少GPX4.4降低铁.
- 3IZH和狄戈辛的组合增强了免疫细胞的透,并显示出显著的抗瘤疗效.
- 开发的策略有效调节了免疫抑制性TME,并显示出有利的安全性.
结论:
- 多功能免疫刺激剂 (3IZH) 在癌症免疫治疗中有望克服TME介导的抗性.
- 同时准GSH,缺氧和免疫逃避是增强抗瘤反应的有效策略.
- 这种设计策略为开发针对复杂瘤的新型组合疗法提供了一个潜在的平台.
相关概念视频
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
The Tumor Microenvironment
7.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K


